Reply to: “Statins in MASLD: Challenges and future directions”

Benzer Materyaller

• Reply to: “Statins in MASLD: Challenges and future directions”
  Yazar:: Vivian D. de Jong, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-09-01)
• Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD
  Yazar:: Xi-Shuang Chen, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-09-01)
• Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study
  Yazar:: Ozge Kama Basci, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-02-01)
• Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank
  Yazar:: Qi Feng, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-07-01)
• Unrecognized Fibrosis Risk in MASLD: A Real-World Analysis and the Case for AI-Augmented Stratification
  Yazar:: Ruona Ebiai, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-01-01)